My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Evolent Health, Inc Class A Common Stock (NY:EVH)

4.120 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Evolent Health (EVH) Q1 2023 Earnings Call Transcript ↗

May 04, 2023

EVH earnings call for the period ending March 31, 2023.

Via The Motley Fool

Recap: Evolent Health Q1 Earnings ↗

May 03, 2023

Via Benzinga

Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector ↗

May 01, 2023

A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...

Via Talk Markets

Biotech And Life Science Trades: Q1 2023 Performance By The Numbers ↗

April 01, 2023

Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...

Via Talk Markets

Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook ↗

February 23, 2023

Via Benzinga

Evolent Health (EVH) Q4 2022 Earnings Call Transcript ↗

February 22, 2023

EVH earnings call for the period ending December 31, 2022.

Via The Motley Fool

Cowen & Co. Maintains Outperform Rating for Evolent Health: Here's What You Need To Know ↗

January 30, 2023

Via Benzinga

Why Evolent Health Stock Is Soaring Today ↗

November 18, 2022

Investors are applauding Evolent's latest acquisition.

Via The Motley Fool

5 Analysts Have This to Say About Evolent Health ↗

November 18, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023 ↗

April 12, 2023

Via Benzinga

SMID Cap Life Science Update: Are You An Investor Or Trader? ↗

February 20, 2023

Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.

Via Talk Markets

Evolent Health (EVH) Q3 2022 Earnings Call Transcript ↗

November 02, 2022

EVH earnings call for the period ending September 30, 2022.

Via The Motley Fool

What 7 Analyst Ratings Have To Say About Evolent Health ↗

October 12, 2022

Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings:

Via Benzinga

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗

February 05, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

Via Talk Markets

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗

November 21, 2022

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.

Via Benzinga

Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday ↗

November 21, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

This Analyst Is Bullish On Evolent Health's Recent Deal, Calls 'Highly Strategic Acquisition' ↗

November 18, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Centene Agrees To Divest Magellan Specialty Health To Evolent Health ↗

November 18, 2022

Via Benzinga

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

Why Evolent Health Stock Sank by Over 6% Today ↗

November 16, 2022

For the second time in nearly as many days, the company's shares got a price target haircut.

Via The Motley Fool

Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday ↗

November 01, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

Can Biotech Stocks Continue Rallying In This Bear Market? ↗

October 31, 2022

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Privia Health Stock Receives IBD Stock Rating Upgrade ↗

October 03, 2022

On Monday, Privia Health stock saw an improvement in its IBD SmartSelect Composite Rating, upgrading to 96 from 94.

Via Investor's Business Daily

Chicago Faith Leaders Plan Coordinated Sermons to Destigmatize Mental Health in Underserved Communities

September 30, 2022

From Evolent Health

Via Business Wire

Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)

September 15, 2022

Via Investor Brand Network

Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)

September 09, 2022

Via Investor Brand Network

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.